Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 40,772 | -225,821 | -121,559 | -83,217 | -61,422 |
| Depreciation Amortization | 7,156 | 3,154 | 727 | 301 | 137 |
| Accounts receivable | -5,899 | 816 | -5,413 | N/A | 0 |
| Accounts payable and accrued liabilities | -610 | 8,444 | 1,905 | -54 | 239 |
| Other Working Capital | -39,083 | -29,030 | 75,363 | 17,406 | 10,514 |
| Other Operating Activity | 221,489 | 39,549 | 12,787 | 10,203 | 6,257 |
| Operating Cash Flow | $223,825 | $-202,888 | $-36,190 | $-55,361 | $-44,275 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,024 | 71,664 | -202,599 | 34,826 | -35,015 |
| PPE Investments | -1,596 | -1,119 | -9 | -179 | -10 |
| Investing Cash Flow | $8,428 | $70,545 | $-202,608 | $34,647 | $-35,025 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 106,000 | N/A | 0 |
| Common Stock Issued | 11,574 | 170,623 | 185,438 | 0 | 0 |
| Other Financing Activity | -23,507 | -7,792 | -2,037 | -818 | 108,689 |
| Financing Cash Flow | $-11,933 | $162,831 | $289,401 | $-818 | $108,689 |
| Exchange Rate Effect | 92 | -17 | -93 | 0 | N/A |
| Beginning Cash Position | 88,838 | 58,367 | 7,857 | 29,389 | 0 |
| End Cash Position | 309,250 | 88,838 | 58,367 | 7,857 | 29,389 |
| Net Cash Flow | $220,412 | $30,471 | $50,510 | $-21,532 | $29,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | 223,825 | -202,888 | -36,190 | -55,361 | -44,275 |
| Capital Expenditure | -1,596 | -1,119 | -9 | -179 | -10 |
| Free Cash Flow | 222,229 | -204,007 | -36,199 | -55,540 | -44,285 |